NEWS, EVENTS, and DEADLINES
July 17, 2023
| |
Upcoming NJ ACTS, Rutgers, Princeton and NJIT Events | |
NCATS, NIH, and Federal News and Events | |
Preparing the Future Workforce in Drug Research & Development A Workshop
The National Academies Forum on Drug Discovery, Development, and Translation will host a public workshop for stakeholders to consider what is needed to support the next generation workforce – one that is resilient, culturally aware, and interdisciplinary. Workshop participants will identify the types of expertise and disciplines needed to achieve the aspirations for a transformed clinical trials enterprise in 2030 and enable a workforce that can better support the evolving needs of drug discovery, development, and translation.
| |
October 16-17, 2023
Location:
National Academy of Sciences Building
2101 Constitution Ave NW
Washington DC 20418
| |
Register to attend
Online or In Person
| |
Women Scientists Advisors Seminar
The NCATS Division of Preclinical Innovation is virtually hosting:
Dr. Dorota Skowronska-Krawczyk, PhD
Center for Translational Vision Research
UC Irvine, School of Medicine
Stress Related Mechanism of Aging - Searching for Drugs that Save Age-Related Vision Loss
| |
| | |
Advancing Representative Enrollment in Clinical Trials
Virtual Public Webinar
July 18, 2023
12 - 4 pm
A lack of representative enrollment can weaken the impact of a clinical trial and skew findings. How can researchers improve the representation of participants included in a clinical trial? The Duke-Margolis Center for Health Policy explores the answer to this question.
| |
Rutgers News and Services | |
REMINDER
Rutgers University Libraries offer research support and can assist with publication compliance issues that otherwise may delay a Notice of Award (NOA) and with data sharing requirements.
| | |
New Guidance Directive from U.S. Department of State
Limits on Remote Participation
J-1 Exchange Visitors may only participate in remote activities up to 40% of the time (e.g., two days out of five per week), beginning on July 1, 2023.
| |
Diversity Funding Opportunity | |
Research Supplements to Promote Diversity in Health-Related Research (Admin Supplement - Clinical Trial Not Allowed) - PA-23-189
NIH is offering funds for administrative supplements to enhance the diversity of the research workforce by recruiting, mentoring, and supporting high school, undergraduate and graduate/clinical students, postbaccalaureate and post Masters individuals, postdoctoral researchers (including health professionals), and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research.
| |
The National Institutes of Health's All of Us Research Program has expanded its data to include nearly a quarter million whole genome sequences for broad research use. Read more! | |
Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) $175M 2023 Appropriation - For fiscal year 2023 TBIPHRP is offering a range of mechanisms to accommodate research across the development spectrum. See Flyer for Details | |
NJ ACTS is a partnership between Rutgers, NJIT and Princeton. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health. | |
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number, UL1TR003017 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
New Jersey Alliance for Clinical and Translational Science
89 French St., Suite 4211
New Brunswick, NJ
Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved
UL1TR003017, KL2TR003018 and TL1TR003019
| | | | |